| Gene symbol | CSF2RA | Synonyms | CD116, CDw116, CSF2R, CSF2RAX, CSF2RAY, CSF2RX, CSF2RY, GM-CSF-R-alpha, GMCSFR, GMCSFR-alpha, GMR, GMR-alpha, SMDP4, alphaGMR | Type of gene | protein-coding |
| Chromosome | X|Y | Map location | X;Y | dbXrefs | |
| Description | colony stimulating factor 2 receptor subunit alpha | ||||
| GTO ID | GTC1116 |
| Trial ID | JPRN-jRCT2033210029 |
| Disease | Acute Myeloid Leukemia |
| Altered gene | GMR |
| Therapeutic/Target gene | Target gene |
| Therapy | CAR-T cell |
| Treatment | GMR CAR-T cells |
| Phase | Phase1|Phase2 |
| Recruitment status | Recruiting |
| Title | Investigator-initiated, first-in-human trial of non-virally engineered GMR CAR T cells against CD116-positive acute myeloid leukemia and juvenile myelomonocytic leukemia. |
| Year | 2021 |
| Country | Japan |
| Company sponsor | Nakazawa Yozo |
| Cohort 1 | |||||||
|
|||||||